TotalMarketCap

Axsome Therapeutics

AXSMNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$6.800 B

$129.28 -5.63%

Close of 6 Nov 2026

As of 6 Nov 2026, Axsome Therapeutics (AXSM) has a market capitalization of $6.80B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$638.5M

#1772 by revenue

Earnings

-$183.2M

Loss-making

Shares outstanding

52,599,985

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #43Rhythm PharmaceuticalsRYTM$7.21B
  2. #44Kiniksa Pharmaceuticals InternationalKNSA$6.95B
  3. #45Axsome TherapeuticsAXSM$6.80B
  4. #46Amneal PharmaceuticalsAMRX$6.78B
  5. #47Ionis PharmaceuticalsIONS$6.43B

What if Axsome Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$536,822.85

Per share 4,152× higher

Bitcoin $1.53T

$29,046.55

Per share 225× higher

Apple $5.02T

$95,357.11

Per share 738× higher

Or at a round number

$10.0B$20.0B$50.0B$100.0B

Where these numbers come from

Share counts and financials for Axsome Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.